The synergistic effect of 5-hydroxytryptamine and epinephrine on the human platelet is related to the activation of phospholipase C

This publication has 22 references indexed in Scilit:

• Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets
  European Journal of Pharmacology: Molecular Pharmacology, 1990
• Epinephrine and the Ca²⁺ ionophore A23187 synergistically induce platelet aggregation without protein kinase C activation
  FEBS Letters, 1989
• Possible mechanisms of the potentiation of blood-platelet activation by adrenaline
  Biochemical Journal, 1987
• Effect on human platelets of catecholamines at levels achieved in the circulation
  Atherosclerosis, 1985
• Rapid intracellular release of calcium in human platelets by stimulation of 5‐HT₂‐receptors
  British Journal of Pharmacology, 1985
• Direct and Sensitizing Effects of Serotonin Agonists and Antagonists on Vascular Smooth Muscle
  Journal of Cardiovascular Pharmacology, 1985
• Platelet-vessel wall interactions: Implication of 5-hydroxytryptamine. A review
  Inflammation Research, 1984
• Stimulation by serotonin of 40 kDa and 20 kDa protein phosphorylation in human platelets
  FEBS Letters, 1984
• Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist
  Inflammation Research, 1982
• Effects of 5-Hydroxytryptamine on Platelet Aggregation
  Nature, 1968